DBV Technologies SA (DBVT)
0.5832
-0.01
(-1.32%)
USD |
NASDAQ |
May 17, 16:00
0.5832
0.00 (0.00%)
After-Hours: 20:00
DBV Technologies Total Return Level: 0.5835 for May 17, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 17, 2024 | 0.5835 |
May 16, 2024 | 0.591 |
May 15, 2024 | 0.5763 |
May 14, 2024 | 0.5895 |
May 13, 2024 | 0.54 |
May 10, 2024 | 0.576 |
May 09, 2024 | 0.5705 |
May 08, 2024 | 0.6938 |
May 07, 2024 | 0.68 |
May 06, 2024 | 0.67 |
May 03, 2024 | 0.6669 |
May 02, 2024 | 0.67 |
May 01, 2024 | 0.69 |
April 30, 2024 | 0.6616 |
April 29, 2024 | 0.6912 |
April 26, 2024 | 0.682 |
April 25, 2024 | 0.6895 |
April 24, 2024 | 0.691 |
April 23, 2024 | 0.68 |
April 22, 2024 | 0.661 |
April 19, 2024 | 0.6817 |
April 18, 2024 | 0.661 |
April 17, 2024 | 0.68 |
April 16, 2024 | 0.7006 |
April 15, 2024 | 0.695 |
Date | Value |
---|---|
April 12, 2024 | 0.6945 |
April 11, 2024 | 0.70 |
April 10, 2024 | 0.7196 |
April 09, 2024 | 0.734 |
April 08, 2024 | 0.7701 |
April 05, 2024 | 0.77 |
April 04, 2024 | 0.70 |
April 03, 2024 | 0.75 |
April 02, 2024 | 0.7649 |
April 01, 2024 | 0.78 |
March 28, 2024 | 0.7491 |
March 27, 2024 | 0.7667 |
March 26, 2024 | 0.7763 |
March 25, 2024 | 0.7849 |
March 22, 2024 | 0.7962 |
March 21, 2024 | 0.80 |
March 20, 2024 | 0.81 |
March 19, 2024 | 0.796 |
March 18, 2024 | 0.77 |
March 15, 2024 | 0.79 |
March 14, 2024 | 0.8129 |
March 13, 2024 | 0.831 |
March 12, 2024 | 0.8614 |
March 11, 2024 | 0.85 |
March 08, 2024 | 0.858 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
0.54
Minimum
May 13 2024
12.98
Maximum
Jan 10 2020
3.736
Average
2.33
Median
Mar 17 2020
Total Return Level Benchmarks
Cellectis SA | 2.99 |
Biophytis SA | 8.26 |
Edap TMS SA | 6.71 |
Genfit SA | 3.759 |
Adaptimmune Therapeutics PLC | 1.11 |